Aclaris Therapeutics Inc (ACRS)
SG&A Expenses
$6.05M
Quarterly · Period ending: · USD
ACRS SG&A Expenses
Latest reported$6.05Mperiod ending
Latest reported$6.05Mperiod ending
ACRS Quarterly SG&A Expenses ($456.50K → $6.05M)
Quarterly SG&A Expenses
High-resolution chart · PNG
ACRS sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 6,048,000 | |
| 6,743,000 | |
| 5,576,000 | |
| 4,871,000 | |
| 5,386,000 | |
| 6,139,000 | |
| 4,954,000 | |
| 5,653,000 | |
| 4,652,000 | |
| 6,844,000 | |
| 8,214,000 | |
| 6,798,000 | |
| 7,296,000 | |
| 8,790,000 | |
| 7,146,000 | |
| 5,813,000 | |
| 6,075,000 | |
| 6,099,000 | |
| 6,943,000 | |
| 5,979,000 | |
| 5,870,000 | |
| 4,827,000 | |
| 4,899,000 | |
| 3,859,000 | |
| 5,572,000 | |
| 6,200,000 | |
| 6,608,000 | |
| 6,286,000 | |
| 15,167,000 | |
| 18,021,000 | |
| 19,661,000 | |
| 17,954,000 | |
| 18,989,000 | |
| 17,493,000 | |
| 11,992,000 | |
| 8,123,000 | |
| 6,330,000 | |
| 5,158,000 | |
| 4,684,000 | |
| 3,650,000 | |
| 3,153,000 | |
| 3,604,000 | |
| 2,400,000 | |
| 1,232,000 | |
| 803,000 | |
| 892,000 | |
| 548,000 | |
| 565,000 | |
| 456,500 | |
| 456,500 |